Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Regulatory Sunset topic

No spam. Unsubscribe anytime.

Panel recommends continuing and modernizing state regulation of controlled‑substance treatment facilities

Colorado House Health & Human Services Committee · February 10, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

OPRRR presented a sunset review recommending continuation of the Colorado Licensing of Controlled Substances Act for 15 years with modernization: update the definition of substance‑use disorder, replace outdated terms with 'withdrawal management,' and make technical edits; BHA testified on oversight role for opioid‑use disorder treatment facilities.

The committee held a sunset review of the Colorado Licensing of Controlled Substances Act, a regulatory framework that authorizes the Behavioral Health Administration (BHA) within CDHS to license facilities that administer controlled substances to treat substance‑use disorders.

Vivian Belmont of the Office of Policy, Research and Regulatory Reform summarized the sunset review and a draft bill that reflects OPRRR recommendations: continue the program for 15 years and modernize statutory language by updating the definition of "substance use disorder," replacing terms such as "detoxification treatment" and "maintenance treatment" with the term "withdrawal management," and making technical edits to eliminate outdated references.

Ryan Mueller, the State Opioid Treatment Authority at BHA, described the agency's role licensing methadone clinics and withdrawal management facilities and said oversight is essential to prevent diversion and ensure safe, effective care. OPRRR noted the program is driven by federal rules (SAMHSA and DEA coordination) and that the changes are intended to codify current practice and modernize terminology.

Committee members discussed the appropriate length of continuation. OPRRR recommended 15 years given the program's close alignment with federal requirements and relatively minor modernization needs; Rep. Johnson moved an amendment to shorten the continuation to 10 years to increase legislative oversight, but the amendment failed 5–8. The committee introduced the draft and approved the continuation as proposed.